Isolated growth hormone deficiency type III Advocacy Hub | UniteRare

At a Glance

Live from database

💊

1FDA treatments

💰

1Open funds

Regulatory Watchboard

1 event

Dec 2017

Macrelin: FDA approved

For the diagnosis of adult growth hormone deficiency

FDAcompleted

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

1 program

FINANCIAL LANDSCAPE SUMMARY

Total programs

Open now

Copay cards

Copay Assistance1

Macrelin

Aeterna Zentaris GmbH

OpenContact for details

View all support programs on disease page →

Approved Treatments

1 FDA-approved

Macrelin

(macimorelin acetate)Orphan drug

Aeterna Zentaris GmbH

Growth Hormone Secretagogue Receptor Agonist [EPC]

12.1 Mechanism of Action Macimorelin stimulates GH release by activating growth hormone secretagogue receptors present in the pituitary and hypothalam...

Approved Dec 2017FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Isolated growth hormone deficiency type III.
Search all trials →

Search clinical trials for Isolated growth hormone deficiency type III →

Recent News & Research

No recent news articles indexed yet for Isolated growth hormone deficiency type III.
Search PubMed for Isolated growth hormone deficiency type III →

Browse all Isolated growth hormone deficiency type III news →

Specialist Network

No specialists currently listed for Isolated growth hormone deficiency type III.

View all Isolated growth hormone deficiency type III specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰